Transaction | Address | Amount |
---|---|---|
0xda2e...9943ed
|
0x197c...d12d77
|
-
1.21875 WETH
·
2,314.16 USD
|
0xda2e...9943ed
|
0x9bf1...5db576
|
+
1.21875 WETH
·
2,314.16 USD
|
0x31c5...14b23c
|
0x3fc9...2b7fad
|
-
0.1 WETH
·
189.88 USD
|
0x31c5...14b23c
|
0x0eec...9ebd23
|
+
0.1 WETH
·
189.88 USD
|
0x31c5...14b23c
|
0x0eec...9ebd23
|
-
450.359456182 NOBODY
|
0x31c5...14b23c
|
0x1795...3e2fac
|
+
450.359456182 NOBODY
|
0x7159...2492e0
|
0x3fc9...2b7fad
|
-
0.087414163109081728 WETH
·
165.98 USD
|
0x7159...2492e0
|
0x87b9...b68e15
|
+
0.087414163109081728 WETH
·
165.98 USD
|
0x7159...2492e0
|
0x87b9...b68e15
|
-
17,851.407389021228143529 FX1
|
0x7159...2492e0
|
0x9e56...7743c7
|
+
17,851.407389021228143529 FX1
|
180 Life Sciences rebrands as ETHZilla, launching a $425M Ethereum treasury to pivot into blockchain finance, utilizing Ethereum as a core asset.
BitMine opts for a $1 billion share repurchase plan, prioritizing buybacks over increasing its Ethereum holdings, as its stock trades below net asset value.
Abraxas Capital faces $100M in unrealized losses on $800M crypto shorts amidst a bullish market.